{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:15:31Z","timestamp":1684642531728},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41409-018-0113-9","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T15:22:16Z","timestamp":1517412136000},"page":"938-941","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant"],"prefix":"10.1038","volume":"53","author":[{"given":"Hafsat","family":"Mashegu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alix","family":"Seif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Grupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Bunin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"113_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D. Gruhn Be, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haematopoietic stem cell transplantation: an open label, phase 3, randomized controlled trial. Lancet. 2012;379:1301\u20139.","journal-title":"Lancet"},{"key":"113_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson G, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157\u201368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"113_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"6","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljrf M, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives- a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;6:781\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"113_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/petr.12730","volume":"5","author":"AL Madenci","year":"2016","unstructured":"Madenci AL, Stetson A, Weldon CB, Lehmann LE. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Pediatr Transplant. 2016;5:687\u201391.","journal-title":"Pediatr Transplant"},{"key":"113_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ctrv.2016.09.014","volume":"50","author":"J Coutsouvelis","year":"2016","unstructured":"Coutsouvelis J, Avery S, Dooley M, Kirkpatrick C, Spencer A. Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haematopoietic stem cell transplantation. Cancer Treat Rev. 2016;50:200\u20134.","journal-title":"Cancer Treat Rev"},{"key":"113_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778\u201383.","journal-title":"Transplantation"},{"key":"113_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116\u201322.","journal-title":"Hepatology"},{"key":"113_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.bbmt.2016.07.011","volume":"10","author":"MA Skeens","year":"2016","unstructured":"Skeens MA, McArthur J, Cheifetz IM, Duncan C, Randolph AG, Stanek J, and HSCT subgroup of the Pediatric Acute Lung Injury & Sepsis Investigators (PALISI). et al. High variability in the reported management of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;10:1823\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"113_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant. 2004;33:189\u201395.","journal-title":"Bone Marrow Transplant"},{"key":"113_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbmt.2017.03.008","volume":"6","author":"PG Richardson","year":"2017","unstructured":"Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, and Defibrotide Study Group. et al. Defibrotide for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome: interim results from a treatment IND study. Biol Blood Marrow Transplant. 2017;6:997\u20131004.","journal-title":"Biol Blood Marrow Transplant"},{"key":"113_CR11","doi-asserted-by":"crossref","unstructured":"Mahadeo KM, McArthur J, Adams RH, Radhi M, Angelo J, Jeyapalan A, et al. Consensus report by PALISI and PBMTC Joint Working Committees, Supportive care guidelines for management of VOD in children and adolescents: Part 2- Focus on ascites; fluids, electrolytes, renal and transfusion issues. Biol Blood Marrow Transplant. 2017;23:2023\u20132033.","DOI":"10.1016\/j.bbmt.2017.08.014"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0113-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:30Z","timestamp":1684617090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0113-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SG has consulted for Jazz Pharmaceuticals. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest:"}}]}}